Does NATALIZUMAB Cause Gait inability? 466 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 466 reports of Gait inability have been filed in association with NATALIZUMAB (TYRUKO). This represents 0.7% of all adverse event reports for NATALIZUMAB.
466
Reports of Gait inability with NATALIZUMAB
0.7%
of all NATALIZUMAB reports
3
Deaths
199
Hospitalizations
How Dangerous Is Gait inability From NATALIZUMAB?
Of the 466 reports, 3 (0.6%) resulted in death, 199 (42.7%) required hospitalization, and 13 (2.8%) were considered life-threatening.
Is Gait inability Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NATALIZUMAB. However, 466 reports have been filed with the FAERS database.
What Other Side Effects Does NATALIZUMAB Cause?
Multiple sclerosis relapse (6,478)
Fatigue (4,456)
Multiple sclerosis (4,078)
Memory impairment (3,024)
Malaise (2,523)
Fall (2,481)
Headache (2,476)
Gait disturbance (2,427)
Prescribed underdose (2,162)
Maternal exposure during pregnancy (1,948)
What Other Drugs Cause Gait inability?
ADALIMUMAB (3,844)
ETANERCEPT (2,710)
METHOTREXATE (2,559)
TOFACITINIB (2,227)
SECUKINUMAB (2,216)
TOCILIZUMAB (2,139)
LEFLUNOMIDE (2,065)
RITUXIMAB (2,028)
ABATACEPT (2,019)
HYDROXYCHLOROQUINE (1,881)
Which NATALIZUMAB Alternatives Have Lower Gait inability Risk?
NATALIZUMAB vs NATALIZUMAB-SZTN
NATALIZUMAB vs NATAMYCIN
NATALIZUMAB vs NATEGLINIDE
NATALIZUMAB vs NAVITOCLAX
NATALIZUMAB vs NAXITAMAB-GQGK